Evolving Indications for Transcatheter Aortic Valve Implantation: Key Issues From Procedural Challenges to Lifetime...

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Prosthetic Heart Valves

Background:

• Transcatheter aortic valve implantation (TAVI) has evolved from treating inoperable patients to a first-line therapy for severe aortic stenosis across all risk groups.
• Expanding indications for TAVI include younger, low-risk, and asymptomatic patients, necessitating a shift towards lifetime valve management.
• Key considerations include optimizing the initial procedure while planning for long-term outcomes like prosthesis durability and reintervention.

Purpose of the Study:

• To review the evolving landscape of Transcatheter Aortic Valve Implantation (TAVI).
• To discuss challenges and strategies for optimizing patient outcomes in the context of lifetime valve management.
• To highlight the importance of device selection, procedural planning, and pharmacologic therapy.

Main Methods:

• Review of current literature and clinical practice guidelines regarding TAVI.
• Analysis of anatomical factors (bicuspid aortic valve, small annulus) and their impact on TAVI outcomes.
• Evaluation of long-term considerations including prosthesis durability, reintervention (TAVI-in-TAVI), and management of conduction disturbances.

Main Results:

• New-generation devices and meticulous planning have improved outcomes despite anatomical challenges like bicuspid aortic valves.
• TAVI-in-TAVI is a feasible reintervention strategy, but challenges with coronary re-access and patient-prosthesis mismatch persist.
• Conduction disturbances and pacemaker implantation remain common, emphasizing technique and pacing strategies.

Conclusions:

• Achieving durable, favorable outcomes with TAVI requires a comprehensive approach integrating anatomical and clinical factors.
• Individualized device selection, lifetime planning, and optimization of pharmacologic therapy are essential for managing patients undergoing TAVI.
• The paradigm shift necessitates balancing immediate procedural success with long-term valve performance and patient well-being.